A Case Study - NeuBase Therapeutics, Inc.
DOI:
https://doi.org/10.5912/jcb995Abstract
NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.
Downloads
Published
2021-09-02
Issue
Section
Article